Herbas VPB

Print
EN | LT
LT - BTK inhibitoriaus, PD-1 inhibitoriaus ir (arba) PD-L1 inhibitoriaus terapiniai deriniai
EN - THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR, A PD-1 INHIBITOR AND/OR A PD-L1 INHIBITOR

Legal status

Patent in force

Claims | Licences/Sublicenses
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 39/395 (2006.01)
A61K 31/00 (2006.01)
A61K 31/4155 (2006.01)
A61K 31/416 (2006.01)
A61K 31/454 (2006.01)
A61K 31/519 (2006.01)
A61K 45/06 (2006.01)
European patent
(11) Number of the document 3179992
(13) Kind of document T
(96) European patent application number 15762756.3
Date of filing the European patent application 2015-08-11
(97) Date of publication of the European application 2017-06-21
(45) Date of publication and mention of the grant of the patent 2022-05-11
(46) Date of publication of the claims translation 2022-06-27
PCT application
(86) Number PCT/IB2015/056123
Date 2015-08-11
PCT application publication
(87) Number WO 2016/024228
Date 2016-02-18
Priority applications
(30) Number Date Country code
201462035812 P 2014-08-11 US
201462088357 P 2014-12-05 US
201562115489 P 2015-02-12 US
201562181164 P 2015-06-17 US
Inventors
(72)
HAMDY, Ahmed , US
ROTHBAUM, Wayne , US
IZUMI, Raquel , US
LANNUTTI, Brian , US
COVEY, Todd , US
ULRICH, Roger , US
JOHNSON, Dave , US
BARF, Tjeerd , NL
KAPTEIN, Allard , NL
Grantee
(73) Acerta Pharma B.V. , Kloosterstraat 9, 5349 AB Oss, NL
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) BTK inhibitoriaus, PD-1 inhibitoriaus ir (arba) PD-L1 inhibitoriaus terapiniai deriniai
  THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR, A PD-1 INHIBITOR AND/OR A PD-L1 INHIBITOR
Last renewal fee
Payment date Validity (years) Amount
2025-07-21 11 289.00 EUR
Next renewal fee
2026-08-11
Last update date 2025-07-23